Position in CPIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$412
+$341 QoQ
Shares Held
127
+170.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $624,876,963 across 66 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
9,213,269 | $133,500,266 | |
| 2 | ZTS |
Zoetis Inc.
|
1,828,326 | $131,383,499 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
583,476 | $98,339,041 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
10,832,582 | $53,404,627 | |
| 5 | VTRS |
Viatris Inc
|
3,135,460 | $49,791,098 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
62,600 | $33,918,552 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
953,413 | $32,301,629 | |
| 8 | HLN |
Haleon plc
|
3,385,489 | $31,586,609 |
All Filings in CPIX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $412 | 127 | Shares | Defined | 2026-05-15 | |
| 2024-06-30 | $71 | 47 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $78 | 47 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $247 | 138 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $279 | 148 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $457 | 311 | Shares | Defined | 2023-08-14 | |
| 2020-09-30 | $6,907 | 2,152 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $7,136 | 2,143 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $399 | 110 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||